“Gastrointestinal cancers can occur anywhere from the esophagus to the rectum. This includes cancers of the esophagus, stomach, small intestine, colon, rectum and anus, as well as the bile duct, pancreas and liver,” said Robert C.G. Martin, M.D., Ph.D., surgical oncologist with Norton Cancer Institute. “They include the second- and third-deadliest cancers in the United…
Jennifer O. Hockenbury, M.D. Pediatric Emergency Medicine Angela M. Jeffries, M.D. Pediatric Gastroenterology Benjamin H. Lyvers, M.D. Pediatric Emergency Medicine Ivory J. Shelton, M.D. Pediatric Emergency Medicine Leena Mohapatra, Ph.D. Pediatric Neurosurgery Jennifer L. Dumey, APRN Child Abuse Pediatrics Missy S Hawes, APRN Pediatrics Julianne Higdon, APRN Pediatric Cardiology Karen L. Jennings, APRN…
Janet L. Smith, M.D. Cardiology Sydney Davidson, PA-C Emergency Medicine Dara Jackson, PA-C Emergency Medicine Kacie L. Albertsen, APRN Head and Neck Surgical Oncology Jannetta Barger, APRN Emergency Medicine Roshana D. Cheek, APRN Orthopedic Surgery Maria F. Daniels, APRN Emergency Medicine Brittany R. Long, APRN Behavioral Oncology
Different substrate mapping techniques are available to identify myocardial sites for catheter ablation in ventricular tachycardia (VT) patients. A recent study has for the first time looked at how well they work compared with one another. Published in the journal Heart Rhythm, the study, “Comparison of Combined Substrate-based Mapping Techniques to Identify Critical Sites for…
Rachel L. Evans, M.D. Pediatric Neurology Stephanie M. Green, D.O. Pediatric Physical Medicine and Rehabilitation Kelly A. Jenkins, M.D. Pediatric Orthopedic Surgery Michael S. Orangias, M.D. Pediatric Pulmonology, Pediatric Sleep Medicine Huma N. Rasheed, M.D. Pediatric Cardiology Zachery T. Sensing, M.D. Hospital Medicine Jennifer Smith, M.D. Pediatric Hospital Medicine Frederick J. Stocker…
Paul A. Adams, M.D. Emergency Medicine Matthew P. Allinder, M.D. Emergency Medicine Austin C. Baker, M.D. Emergency Medicine Jared S. Bass, D.O. Emergency Medicine Shannon M. Becht, M.D. Emergency Medicine Kristen Bublitz, D.O. Emergency Medicine Victoria Buescher, M.D. Internal Medicine Richard D. Carlisle, M.D. Emergency Medicine Gang Cheng, M.D. Cardiology Charlotte R. Crowley, M.D. Emergency…
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity and minimally invasive techniques. “I try to develop a relationship with my patients and partner with them to get the…
Christie Buonpane, M.D. Pediatric General Surgery Claire E. Milligan, Ph.D. Pediatric Psychology Kathryn R. Gallegos, APRN Pediatric Neurology Austin Peters, APRN Pediatrics Corinne M. Streble, APRN Pediatric Cardiology
George Gad, M.D. Hospital Medicine Nathan Gonda, D.O. Emergency Medicine Sarah B. Radtke, M.D. Obstetrics/ Gynecology Lauren M. Strait, M.D. Vascular Surgery Molly E. Tuller, M.D. Obstetrics/Gynecology Tracey D. Wolford, M.D. Gastroenterology Maureen Carberry, PA-C Colon and Rectal Surgery Caitlin C. Crowley, PA-C Pulmonology Emily Mathews, PA-C Emergency Medicine Felecia Q. Carey, APRN Urgent Care…
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and children ages 8 and older with Stage 2 Type 1 diabetes. “Delaying the onset of Stage 3 not only postpones…
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton Children’s is one of 40 sites nationally participating in the Phase 3 trial. Afrezza is an ultra-fast-acting inhaled mealtime insulin,…
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric neuro-oncologist at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, looks at whether DFMO offers a new…